1Winter JN,Lazarus HM,Rademaker A,et al.Phase Ⅰ/Ⅱ study of combined granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells[J].J Clin Oncol,1996,14(1):277-286.
2Arora M,Bums LJ,Barker JN,et al.Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma[J].Biol Blood Marrow Transplant,2004,10(6):395-404.
3Zhang ZX,Yang L,Young KJ,et al.Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression[J].Nature Medicine,2000,6(7):782-789
4Young JK,DuTemple B,Phillips MJ,et al.Inhibition of graftversus-host disease by donble-negative regulatory T cells[J].The Journal ofImmunology,2003,171(1):134-141.
5Fond MS,Young KJ,Zhang Z,et al.The immune regulatory function of lympboproliferative double negative T cells in vitro and in Vivo[J].The Journal of Experimental Medicine,2002,196(2):261-267.
6Champlin RE,Schmitz N,Horowitz MM,et al.Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation.IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)[J].Blood,2000,95(12):3702-3709.
7Couban S,Simpson DR,Barnett MJ,et al.A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies[J].Blood,2002,100(5):1525-1531.
8Ringdén O,Labopin M,Bacigalupo A,et al.Transplantation of peripheral blood stem cells as compared with bone marrow from HIA-identical siblings in aduh patients with acute myeloid leukemia and acute lymphoblastic leukemia[J].J Clin Oncol,2002,20(24):4655-4664.
9Fowler DH,Kurasawa K,Smith R,et al.Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice[J].Blood,1994,84(10):3540-3549.
10Pan L,Delmonte J,Jalonen CK,et al.Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease[J].Blood,1995,86(12):4422-4429.
